This comprehensive health news roundup highlights a tragic diphtheria case in Germany, vaccine and abortion-related scrutiny ...

Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre ...

U.K. stocks are quite subdued in cautious trade Wednesday morning as investors await the Federal Reserve's monetary policy ...

Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre ...

Wall Street is bracing for a sharp decline in U.S. oil refiners' fourth-quarter profits as fuel demand softened, while seeking clarity on the sector's preparations for President Donald Trump's ...

In an exclusive poll for City AM, Joanna Hodgson surveys major firms to see if hybrid working is still king in the UK ...

Listen to this article President Donald Trump has ordered a freeze on more than $3 trillion in federal financial assistance, including grants and loans backing economic development and infrastructure ...

The maker of Advil, Tums and Sensodyne toothpaste is investing $54.2 million to upgrade its global research and development ...

Haleon PLC closed 5.73% below its 52-week high of £4.01, which the company reached on September 18th.

The UK-based consumer healthcare company will be modernizing its facility along Brook Road, where it conducts R&D for such ...

The global antacids market is on track for substantial expansion, with projections indicating a rise from USD 6,971.2 million ...

Haleon, a global consumer health company behind products like Advil, Aquafresh and Polident, announced a $54.2 million ...